DENISE PERUSKI: Open Payments
NPI 1043730278 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 41 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $433 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $219 |
| Novo Nordisk Inc | 9 | $150 |
| Amgen Inc. | 3 | $48 |
| Corcept Therapeutics | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Insulet Corporation | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Boston Scientific Corporation | 1 | $23 |
Products named: BREZTRI, JARDIANCE, Ozempic, Korlym, VOQUEZNA, ELIQUIS, Wegovy, Rybelsus.
Industry payments across ID — which companies pay providers there.
